Cardiotoxicity is an escalating challenge in healthcare with the increasing use of cancer therapies known to cause cardiovascular damage.

The COMPASS project aims to optimize cardiovascular health for cancer patients and survivors through a comprehensive, patient centered clinical pathway over five years. It will advance cardio-oncology research by creating an international network and developing tools for better disease prediction, prevention, diagnosis, and management.

The project focuses on integrating cardio-oncology care pathways, optimizing diagnostic biomarkers, and utilizing AI-supported imaging and wearable technologies for early detection and personalized treatment, while promoting sustainable healthcare delivery and reducing environmental impact.